Difference between revisions of "About-cancer/treatment/drugs/related-conditions"
(Marked this version for translation) |
|||
| Line 1: | Line 1: | ||
<languages/> | <languages/> | ||
<translate> | <translate> | ||
| − | == Drugs Approved for Conditions Related to Cancer == | + | == Drugs Approved for Conditions Related to Cancer == <!--T:1--> |
| + | <!--T:2--> | ||
People with cancer may have other conditions caused by the cancer or its treatment. Drugs approved by the FDA for some of these cancer-related conditions are listed on this page. The drug names link to NCI's Cancer Drug Information summaries that provide information about these drugs. There may be other drugs used in these conditions that are not listed here. | People with cancer may have other conditions caused by the cancer or its treatment. Drugs approved by the FDA for some of these cancer-related conditions are listed on this page. The drug names link to NCI's Cancer Drug Information summaries that provide information about these drugs. There may be other drugs used in these conditions that are not listed here. | ||
| + | <!--T:3--> | ||
'''Actinic Keratosis''' | '''Actinic Keratosis''' | ||
| + | <!--T:4--> | ||
Aminolevulinic Acid (Ameluz, Levulan Kerastik) | Aminolevulinic Acid (Ameluz, Levulan Kerastik) | ||
| + | <!--T:5--> | ||
Fluorouracil--Topical (5-FU, Carac, Efudex, Fluoroplex, Tolak) | Fluorouracil--Topical (5-FU, Carac, Efudex, Fluoroplex, Tolak) | ||
| + | <!--T:6--> | ||
Imiquimod (Aldara) | Imiquimod (Aldara) | ||
| + | <!--T:7--> | ||
'''Aggressive Systemic Mastocytosis''' | '''Aggressive Systemic Mastocytosis''' | ||
| + | <!--T:8--> | ||
Imatinib Mesylate (Gleevec) | Imatinib Mesylate (Gleevec) | ||
| + | <!--T:9--> | ||
Midostaurin (Rydapt) | Midostaurin (Rydapt) | ||
| + | <!--T:10--> | ||
'''Anemia (Low Red Blood Cells)''' | '''Anemia (Low Red Blood Cells)''' | ||
| + | <!--T:11--> | ||
Darbepoetin Alfa (Aranesp) | Darbepoetin Alfa (Aranesp) | ||
| + | <!--T:12--> | ||
Dexamethasone | Dexamethasone | ||
| + | <!--T:13--> | ||
Epoetin Alfa (Epogen, Procrit, Retacrit) | Epoetin Alfa (Epogen, Procrit, Retacrit) | ||
| + | <!--T:14--> | ||
Lenalidomide (Revlimid) | Lenalidomide (Revlimid) | ||
| + | <!--T:15--> | ||
Prednisone | Prednisone | ||
| + | <!--T:16--> | ||
'''Carcinoid Syndrome''' | '''Carcinoid Syndrome''' | ||
| + | <!--T:17--> | ||
Lanreotide Acetate (Somatuline Depot) | Lanreotide Acetate (Somatuline Depot) | ||
| + | <!--T:18--> | ||
'''Cardiac Toxicity (Heart Side Effects)''' | '''Cardiac Toxicity (Heart Side Effects)''' | ||
| + | <!--T:19--> | ||
Dexrazoxane Hydrochloride (Zinecard) | Dexrazoxane Hydrochloride (Zinecard) | ||
| + | <!--T:20--> | ||
Uridine Triacetate (Vistogard) | Uridine Triacetate (Vistogard) | ||
| + | <!--T:21--> | ||
'''Condyloma Acuminatum (Genital Warts)''' | '''Condyloma Acuminatum (Genital Warts)''' | ||
| + | <!--T:22--> | ||
Imiquimod (Aldara) | Imiquimod (Aldara) | ||
| + | <!--T:23--> | ||
Recombinant Human Papillomavirus (HPV) Nonavalent Vaccine (Gardasil 9) | Recombinant Human Papillomavirus (HPV) Nonavalent Vaccine (Gardasil 9) | ||
| + | <!--T:24--> | ||
Recombinant Human Papillomavirus (HPV) Quadrivalent Vaccine (Gardasil) | Recombinant Human Papillomavirus (HPV) Quadrivalent Vaccine (Gardasil) | ||
| + | <!--T:25--> | ||
Recombinant Interferon Alfa-2b (Intron A) | Recombinant Interferon Alfa-2b (Intron A) | ||
| + | <!--T:26--> | ||
'''Constipation''' | '''Constipation''' | ||
| + | <!--T:27--> | ||
Methylnaltrexone Bromide (Relistor) | Methylnaltrexone Bromide (Relistor) | ||
| + | <!--T:28--> | ||
'''Cytokine Release Syndrome''' | '''Cytokine Release Syndrome''' | ||
| + | <!--T:29--> | ||
Tocilizumab (Actemra) | Tocilizumab (Actemra) | ||
| + | <!--T:30--> | ||
'''Drug Extravasation (Drug Leakage in Tissues)''' | '''Drug Extravasation (Drug Leakage in Tissues)''' | ||
| + | <!--T:31--> | ||
Dexrazoxane Hydrochloride (Totect) | Dexrazoxane Hydrochloride (Totect) | ||
| + | <!--T:32--> | ||
'''Drug Toxicity (Severe Side Effects)''' | '''Drug Toxicity (Severe Side Effects)''' | ||
| + | <!--T:33--> | ||
Amifostine (Ethyol)—for Cisplatin Toxicity | Amifostine (Ethyol)—for Cisplatin Toxicity | ||
| + | <!--T:34--> | ||
Dexamethasone | Dexamethasone | ||
| + | <!--T:35--> | ||
Dexrazoxane Hydrochloride (Zinecard)—for Doxorubicin Toxicity | Dexrazoxane Hydrochloride (Zinecard)—for Doxorubicin Toxicity | ||
| + | <!--T:36--> | ||
Glucarpidase (Voraxaze)—for Methotrexate Toxicity | Glucarpidase (Voraxaze)—for Methotrexate Toxicity | ||
| + | <!--T:37--> | ||
Uridine Triacetate (Vistogard)—for Capecitabine or Fluorouracil Toxicity | Uridine Triacetate (Vistogard)—for Capecitabine or Fluorouracil Toxicity | ||
| + | <!--T:38--> | ||
'''Hemophagocytic Lymphohistiocytosis''' | '''Hemophagocytic Lymphohistiocytosis''' | ||
| + | <!--T:39--> | ||
Emapalumab-lzsg (Gamifant) | Emapalumab-lzsg (Gamifant) | ||
| + | <!--T:40--> | ||
'''Hemorrhagic Cystitis (Bleeding in the Bladder)''' | '''Hemorrhagic Cystitis (Bleeding in the Bladder)''' | ||
| + | <!--T:41--> | ||
Mesna (Mesnex) | Mesna (Mesnex) | ||
| + | <!--T:42--> | ||
'''Hepatic Veno-occlusive Disease (Blocked Liver Veins)''' | '''Hepatic Veno-occlusive Disease (Blocked Liver Veins)''' | ||
| + | <!--T:43--> | ||
Defibrotide Sodium (Defitelio) | Defibrotide Sodium (Defitelio) | ||
| + | <!--T:44--> | ||
'''Hepatitis C Infection''' | '''Hepatitis C Infection''' | ||
| + | <!--T:45--> | ||
Peginterferon Alfa-2b (PEG-Intron) | Peginterferon Alfa-2b (PEG-Intron) | ||
| + | <!--T:46--> | ||
'''Hypercalcemia of Malignancy (High Blood Calcium)''' | '''Hypercalcemia of Malignancy (High Blood Calcium)''' | ||
| + | <!--T:47--> | ||
Denosumab (Xgeva) | Denosumab (Xgeva) | ||
| + | <!--T:48--> | ||
Dexamethasone | Dexamethasone | ||
| + | <!--T:49--> | ||
Pamidronate Disodium (Aredia) | Pamidronate Disodium (Aredia) | ||
| + | <!--T:50--> | ||
Prednisone | Prednisone | ||
| + | <!--T:51--> | ||
Zoledronic Acid (Zometa) | Zoledronic Acid (Zometa) | ||
| + | <!--T:52--> | ||
'''Malignant Effusion''' | '''Malignant Effusion''' | ||
| + | <!--T:53--> | ||
Bleomycin | Bleomycin | ||
| + | <!--T:54--> | ||
Mechlorethamine Hydrochloride (Mustargen) | Mechlorethamine Hydrochloride (Mustargen) | ||
| + | <!--T:55--> | ||
Talc (Sterile Talc Powder, Sclerosol Intrapleural Aerosol, Steritalc) | Talc (Sterile Talc Powder, Sclerosol Intrapleural Aerosol, Steritalc) | ||
| + | <!--T:56--> | ||
Thiotepa | Thiotepa | ||
| + | <!--T:57--> | ||
'''Mucositis (Inflamed Mucous Membranes)''' | '''Mucositis (Inflamed Mucous Membranes)''' | ||
| + | <!--T:58--> | ||
Palifermin (Kepivance) | Palifermin (Kepivance) | ||
| + | <!--T:59--> | ||
'''Nausea and Vomiting''' | '''Nausea and Vomiting''' | ||
| + | <!--T:60--> | ||
Aprepitant (Emend) | Aprepitant (Emend) | ||
| + | <!--T:61--> | ||
Granisetron (Sancuso, Sustol) | Granisetron (Sancuso, Sustol) | ||
| + | <!--T:62--> | ||
Granisetron Hydrochloride | Granisetron Hydrochloride | ||
| + | <!--T:63--> | ||
Netupitant and Palonosetron Hydrochloride (Akynzeo) | Netupitant and Palonosetron Hydrochloride (Akynzeo) | ||
| + | <!--T:64--> | ||
Ondansetron Hydrochloride (Zofran) | Ondansetron Hydrochloride (Zofran) | ||
| + | <!--T:65--> | ||
Palonosetron Hydrochloride (Aloxi) | Palonosetron Hydrochloride (Aloxi) | ||
| + | <!--T:66--> | ||
Rolapitant Hydrochloride (Varubi) | Rolapitant Hydrochloride (Varubi) | ||
| + | <!--T:67--> | ||
'''Neurotoxicity (Nervous System Side Effects)''' | '''Neurotoxicity (Nervous System Side Effects)''' | ||
| + | <!--T:68--> | ||
Uridine Triacetate (Vistogard) | Uridine Triacetate (Vistogard) | ||
| + | <!--T:69--> | ||
'''Neutropenia (Low Blood Neutrophils)''' | '''Neutropenia (Low Blood Neutrophils)''' | ||
| + | <!--T:70--> | ||
Filgrastim (Granix, Neupogen, Zarxio) | Filgrastim (Granix, Neupogen, Zarxio) | ||
| + | <!--T:71--> | ||
Pegfilgrastim (Neulasta) | Pegfilgrastim (Neulasta) | ||
| + | <!--T:72--> | ||
'''Osteoporosis (Loss of Bone Density)''' | '''Osteoporosis (Loss of Bone Density)''' | ||
| + | <!--T:73--> | ||
Denosumab (Prolia) | Denosumab (Prolia) | ||
| + | <!--T:74--> | ||
Raloxifene Hydrochloride (Evista) | Raloxifene Hydrochloride (Evista) | ||
| + | <!--T:75--> | ||
'''Paroxysmal Nocturnal Hemoglobinuria''' | '''Paroxysmal Nocturnal Hemoglobinuria''' | ||
| + | <!--T:76--> | ||
Ravulizumab-cwvz (Ultomiris) | Ravulizumab-cwvz (Ultomiris) | ||
| + | <!--T:77--> | ||
'''Renal Toxicity (Kidney Side Effects)''' | '''Renal Toxicity (Kidney Side Effects)''' | ||
| + | <!--T:78--> | ||
Amifostine (Ethyol) | Amifostine (Ethyol) | ||
| + | <!--T:79--> | ||
'''Skin Changes Due to Cutaneous Metastases''' | '''Skin Changes Due to Cutaneous Metastases''' | ||
| + | <!--T:80--> | ||
Bexarotene (Targretin) | Bexarotene (Targretin) | ||
| + | <!--T:81--> | ||
'''Thrombocytopenia (Low Blood Platelets)''' | '''Thrombocytopenia (Low Blood Platelets)''' | ||
| + | <!--T:82--> | ||
Caplacizumab-yhdp (Cablivi) | Caplacizumab-yhdp (Cablivi) | ||
| + | <!--T:83--> | ||
Dexamethasone | Dexamethasone | ||
| + | <!--T:84--> | ||
Eltrombopag Olamine (Promacta) | Eltrombopag Olamine (Promacta) | ||
| + | <!--T:85--> | ||
Fostamatinib Disodium (Tavalisse) | Fostamatinib Disodium (Tavalisse) | ||
| + | <!--T:86--> | ||
Prednisone | Prednisone | ||
| + | <!--T:87--> | ||
Romiplostim (Nplate) | Romiplostim (Nplate) | ||
| + | <!--T:88--> | ||
'''Tumor Lysis Syndrome (Cell Breakdown and Organ Damage)''' | '''Tumor Lysis Syndrome (Cell Breakdown and Organ Damage)''' | ||
| + | <!--T:89--> | ||
Rasburicase (Elitek) | Rasburicase (Elitek) | ||
| + | <!--T:90--> | ||
'''Xerostomia (Dry Mouth)''' | '''Xerostomia (Dry Mouth)''' | ||
| + | <!--T:91--> | ||
Amifostine (Ethyol) | Amifostine (Ethyol) | ||
</translate> | </translate> | ||
Latest revision as of 21:39, 29 October 2019
Drugs Approved for Conditions Related to Cancer
People with cancer may have other conditions caused by the cancer or its treatment. Drugs approved by the FDA for some of these cancer-related conditions are listed on this page. The drug names link to NCI's Cancer Drug Information summaries that provide information about these drugs. There may be other drugs used in these conditions that are not listed here.
Actinic Keratosis
Aminolevulinic Acid (Ameluz, Levulan Kerastik)
Fluorouracil--Topical (5-FU, Carac, Efudex, Fluoroplex, Tolak)
Imiquimod (Aldara)
Aggressive Systemic Mastocytosis
Imatinib Mesylate (Gleevec)
Midostaurin (Rydapt)
Anemia (Low Red Blood Cells)
Darbepoetin Alfa (Aranesp)
Dexamethasone
Epoetin Alfa (Epogen, Procrit, Retacrit)
Lenalidomide (Revlimid)
Prednisone
Carcinoid Syndrome
Lanreotide Acetate (Somatuline Depot)
Cardiac Toxicity (Heart Side Effects)
Dexrazoxane Hydrochloride (Zinecard)
Uridine Triacetate (Vistogard)
Condyloma Acuminatum (Genital Warts)
Imiquimod (Aldara)
Recombinant Human Papillomavirus (HPV) Nonavalent Vaccine (Gardasil 9)
Recombinant Human Papillomavirus (HPV) Quadrivalent Vaccine (Gardasil)
Recombinant Interferon Alfa-2b (Intron A)
Constipation
Methylnaltrexone Bromide (Relistor)
Cytokine Release Syndrome
Tocilizumab (Actemra)
Drug Extravasation (Drug Leakage in Tissues)
Dexrazoxane Hydrochloride (Totect)
Drug Toxicity (Severe Side Effects)
Amifostine (Ethyol)—for Cisplatin Toxicity
Dexamethasone
Dexrazoxane Hydrochloride (Zinecard)—for Doxorubicin Toxicity
Glucarpidase (Voraxaze)—for Methotrexate Toxicity
Uridine Triacetate (Vistogard)—for Capecitabine or Fluorouracil Toxicity
Hemophagocytic Lymphohistiocytosis
Emapalumab-lzsg (Gamifant)
Hemorrhagic Cystitis (Bleeding in the Bladder)
Mesna (Mesnex)
Hepatic Veno-occlusive Disease (Blocked Liver Veins)
Defibrotide Sodium (Defitelio)
Hepatitis C Infection
Peginterferon Alfa-2b (PEG-Intron)
Hypercalcemia of Malignancy (High Blood Calcium)
Denosumab (Xgeva)
Dexamethasone
Pamidronate Disodium (Aredia)
Prednisone
Zoledronic Acid (Zometa)
Malignant Effusion
Bleomycin
Mechlorethamine Hydrochloride (Mustargen)
Talc (Sterile Talc Powder, Sclerosol Intrapleural Aerosol, Steritalc)
Thiotepa
Mucositis (Inflamed Mucous Membranes)
Palifermin (Kepivance)
Nausea and Vomiting
Aprepitant (Emend)
Granisetron (Sancuso, Sustol)
Granisetron Hydrochloride
Netupitant and Palonosetron Hydrochloride (Akynzeo)
Ondansetron Hydrochloride (Zofran)
Palonosetron Hydrochloride (Aloxi)
Rolapitant Hydrochloride (Varubi)
Neurotoxicity (Nervous System Side Effects)
Uridine Triacetate (Vistogard)
Neutropenia (Low Blood Neutrophils)
Filgrastim (Granix, Neupogen, Zarxio)
Pegfilgrastim (Neulasta)
Osteoporosis (Loss of Bone Density)
Denosumab (Prolia)
Raloxifene Hydrochloride (Evista)
Paroxysmal Nocturnal Hemoglobinuria
Ravulizumab-cwvz (Ultomiris)
Renal Toxicity (Kidney Side Effects)
Amifostine (Ethyol)
Skin Changes Due to Cutaneous Metastases
Bexarotene (Targretin)
Thrombocytopenia (Low Blood Platelets)
Caplacizumab-yhdp (Cablivi)
Dexamethasone
Eltrombopag Olamine (Promacta)
Fostamatinib Disodium (Tavalisse)
Prednisone
Romiplostim (Nplate)
Tumor Lysis Syndrome (Cell Breakdown and Organ Damage)
Rasburicase (Elitek)
Xerostomia (Dry Mouth)
Amifostine (Ethyol)
